Optometrists in Summerfield, NC Accepting Medicare
3 Optometrists found. Showing 1 - 3
 Dr. Sarah H Barts, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7309b Summerfield Rd, Summerfield, NC 27358 Phone: 336-644-0802 Fax: 336-441-8522 |
 Sarah H Barts, Od, Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7309b Summerfield Rd, Summerfield, NC 27358 Phone: 336-644-0802 Fax: 336-644-0680 |
Thurmond Eye Center Od Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1015 Hwy 150 West, Suite D, Summerfield, NC 27358 Phone: 336-281-2015 |
News Archive
MGH scientists use electronic health records for early diagnosis of dementia
A team of scientists from Massachusetts General Hospital has developed a software-based method of scanning electronic health records to estimate the risk that a healthy person will receive a dementia diagnosis in the future.
Adolescent declines in cognitive performance predict later psychosis
Adolescents and young adults experiencing relative declines in cognitive performance have an increased risk for later psychosis, with a decline in verbal ability between 13 and 18 years of age a strong predictor, conclude researchers.
Study on hand osteoarthritis
In just two years, patients with hand osteoarthritis (OA) experienced a significant increase in pain and functional limitations, according to new data presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain. Statistically significant radiological progression was also detected in 20% of subjects.
Access Systems awarded $3.5M contract to support HHS FTS2001-Networx Transition Program Management Office
Access Systems, Inc. (ACCESS), an information technology (IT) solutions provider, has been awarded a $3.5M contract by GSA's National Capital Region to support the Department of Health and Human Services (HHS) FTS2001-Networx Transition Program Management Office. ACCESS and team partner, BCCP Consulting, LLC, will assist HHS to conduct Fair Opportunity for selecting the Networx vendors that will provide telecommunications and associated professional services to the HHS OPDIVs.
Patient dosing in CyDex Pharmaceuticals' Phase 2A clinical trial of CDX-353 initiated
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
› Verified 6 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists
Chiropractors